DarioHealth Corp.
DRIO
$6.28
$0.223.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.58M | 5.23M | 5.01M | 5.37M | 6.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.58M | 5.23M | 5.01M | 5.37M | 6.75M |
| Cost of Revenue | 2.21M | 2.25M | 1.81M | 1.97M | 2.00M |
| Gross Profit | 3.38M | 2.99M | 3.20M | 3.40M | 4.76M |
| SG&A Expenses | 8.12M | 8.73M | 9.17M | 8.44M | 9.18M |
| Depreciation & Amortization | 177.00K | 181.00K | 181.00K | 433.00K | 875.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.89M | 13.79M | 14.49M | 14.57M | 16.16M |
| Operating Income | -7.31M | -8.56M | -9.48M | -9.20M | -9.41M |
| Income Before Tax | -8.19M | -8.95M | -10.47M | -12.99M | -9.21M |
| Income Tax Expenses | 57.00K | 83.00K | -- | -- | 22.00K |
| Earnings from Continuing Operations | -8.25M | -9.03M | -10.47M | -12.99M | -9.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.25M | -9.03M | -10.47M | -12.99M | -9.23M |
| EBIT | -7.31M | -8.56M | -9.48M | -9.20M | -9.41M |
| EBITDA | -6.79M | -8.03M | -8.94M | -8.40M | -8.15M |
| EPS Basic | -1.25 | -2.04 | -2.96 | -3.54 | -2.87 |
| Normalized Basic EPS | -0.78 | -0.71 | -2.08 | -3.27 | -2.43 |
| EPS Diluted | -1.25 | -2.04 | -2.96 | -3.54 | -2.87 |
| Normalized Diluted EPS | -0.78 | -0.71 | -2.08 | -3.27 | -2.43 |
| Average Basic Shares Outstanding | 6.58M | 7.91M | 3.14M | 2.48M | 2.37M |
| Average Diluted Shares Outstanding | 6.58M | 7.91M | 3.14M | 2.48M | 2.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |